Mer­ck and Ei­sai's Keytru­da/Lenvi­ma com­bo fails PhI­II tri­als for melanoma, col­orec­tal can­cer

Since 2018 — when Mer­ck and Ei­sai kicked off their col­lab­o­ra­tion to com­bine and test out Keytru­da and Lenvi­ma against mul­ti­ple can­cers — the two-drug com­bo has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.